DEO vs LENZ · P/E 16, $55.86B cap vs rev $7.4M
Diageo PLC ADR (DEO) versus LENZ Therapeutics Inc (LENZ) — a side-by-side from cached financials, not a winner call.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
DEO does not have a complete income-statement cache yet.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
DEO currently screens at market cap $55.86B and trailing P/E 15.6. LENZ currently screens at market cap $223.6M.
Not investment advice. Open the DEO and LENZ stock pages for the full models.
Not investment advice.